Cargando…

Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm

BACKGROUND: Accelerated idioventricular rhythm (AIVR) is often transient, considered benign and requires no treatment. This observational study aims to investigate the clinical manifestations, treatment, and prognosis of frequent AIVR. METHODS: Twenty-seven patients (20 male; mean age 32.2 ± 17.0 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lan, Liu, Hailei, Zhu, Chao, Gu, Kai, Yang, Gang, Chen, Hongwu, Ju, Weizhu, Li, Mingfang, Zhang, Fengxiang, Yang, Bing, Wang, Dao Wu, Chen, Minglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427942/
https://www.ncbi.nlm.nih.gov/pubmed/34496747
http://dx.doi.org/10.1186/s12872-021-02221-0
_version_ 1783750277011079168
author Wang, Lan
Liu, Hailei
Zhu, Chao
Gu, Kai
Yang, Gang
Chen, Hongwu
Ju, Weizhu
Li, Mingfang
Zhang, Fengxiang
Yang, Bing
Wang, Dao Wu
Chen, Minglong
author_facet Wang, Lan
Liu, Hailei
Zhu, Chao
Gu, Kai
Yang, Gang
Chen, Hongwu
Ju, Weizhu
Li, Mingfang
Zhang, Fengxiang
Yang, Bing
Wang, Dao Wu
Chen, Minglong
author_sort Wang, Lan
collection PubMed
description BACKGROUND: Accelerated idioventricular rhythm (AIVR) is often transient, considered benign and requires no treatment. This observational study aims to investigate the clinical manifestations, treatment, and prognosis of frequent AIVR. METHODS: Twenty-seven patients (20 male; mean age 32.2 ± 17.0 years) diagnosed with frequent AIVR were enrolled in our study. Inclusion criteria were as follows: (1) at least three recordings of AIVR on 24-h Holter monitoring with an interval of over one month between each recording; and (2) resting ectopic ventricular rate between 50 to 110 bpm on ECG. Electrophysiological study (EPS) and catheter ablation were performed in patients with distinct indications. RESULTS: All 27 patients experienced palpitation or chest discomfort, and two had syncope or presyncope on exertion. Impaired left ventricular ejection fraction (LVEF) was identified in 5 patients, and LVEF was negatively correlated with AIVR burden (P < 0.001). AIVR burden of over 73.8%/day could predict impaired LVEF with a sensitivity of 100% and specificity of 94.1%. Seventeen patients received EPS and ablation, five of whom had decreased LVEF. During a median follow-up of 60 (32, 84) months, LVEF of patients with impaired LV function returned to normal levels 6 months post-discharge, except one with dilated cardiomyopathy (DCM). Two patients died during follow-up. The DCM patient died due to late stage of heart failure, and another patient who refused ablation died of AIVR over-acceleration under fever. CONCLUSIONS: Frequent AIVR has unique clinical manifestations. AIVR patients with burden of over 70%, impaired LVEF, and/or symptoms of syncope or presyncope due to over-response to sympathetic tone should be considered for catheter ablation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02221-0.
format Online
Article
Text
id pubmed-8427942
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84279422021-09-10 Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm Wang, Lan Liu, Hailei Zhu, Chao Gu, Kai Yang, Gang Chen, Hongwu Ju, Weizhu Li, Mingfang Zhang, Fengxiang Yang, Bing Wang, Dao Wu Chen, Minglong BMC Cardiovasc Disord Research BACKGROUND: Accelerated idioventricular rhythm (AIVR) is often transient, considered benign and requires no treatment. This observational study aims to investigate the clinical manifestations, treatment, and prognosis of frequent AIVR. METHODS: Twenty-seven patients (20 male; mean age 32.2 ± 17.0 years) diagnosed with frequent AIVR were enrolled in our study. Inclusion criteria were as follows: (1) at least three recordings of AIVR on 24-h Holter monitoring with an interval of over one month between each recording; and (2) resting ectopic ventricular rate between 50 to 110 bpm on ECG. Electrophysiological study (EPS) and catheter ablation were performed in patients with distinct indications. RESULTS: All 27 patients experienced palpitation or chest discomfort, and two had syncope or presyncope on exertion. Impaired left ventricular ejection fraction (LVEF) was identified in 5 patients, and LVEF was negatively correlated with AIVR burden (P < 0.001). AIVR burden of over 73.8%/day could predict impaired LVEF with a sensitivity of 100% and specificity of 94.1%. Seventeen patients received EPS and ablation, five of whom had decreased LVEF. During a median follow-up of 60 (32, 84) months, LVEF of patients with impaired LV function returned to normal levels 6 months post-discharge, except one with dilated cardiomyopathy (DCM). Two patients died during follow-up. The DCM patient died due to late stage of heart failure, and another patient who refused ablation died of AIVR over-acceleration under fever. CONCLUSIONS: Frequent AIVR has unique clinical manifestations. AIVR patients with burden of over 70%, impaired LVEF, and/or symptoms of syncope or presyncope due to over-response to sympathetic tone should be considered for catheter ablation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-021-02221-0. BioMed Central 2021-09-08 /pmc/articles/PMC8427942/ /pubmed/34496747 http://dx.doi.org/10.1186/s12872-021-02221-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Lan
Liu, Hailei
Zhu, Chao
Gu, Kai
Yang, Gang
Chen, Hongwu
Ju, Weizhu
Li, Mingfang
Zhang, Fengxiang
Yang, Bing
Wang, Dao Wu
Chen, Minglong
Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title_full Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title_fullStr Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title_full_unstemmed Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title_short Clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
title_sort clinical characteristics and therapeutic strategy of frequent accelerated idioventricular rhythm
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427942/
https://www.ncbi.nlm.nih.gov/pubmed/34496747
http://dx.doi.org/10.1186/s12872-021-02221-0
work_keys_str_mv AT wanglan clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT liuhailei clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT zhuchao clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT gukai clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT yanggang clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT chenhongwu clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT juweizhu clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT limingfang clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT zhangfengxiang clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT yangbing clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT wangdaowu clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm
AT chenminglong clinicalcharacteristicsandtherapeuticstrategyoffrequentacceleratedidioventricularrhythm